Humatrope and Hyperkalemia - a phase IV clinical study of FDA data

Summary:

Hyperkalemia is reported as a side effect among people who take Humatrope (somatropin recombinant), especially for people who are female, 40-49 old, have been taking the drug for 2 - 5 years also take Florinef, and have Cardiac failure.

The phase IV clinical study analyzes which people have Hyperkalemia when taking Humatrope. It is created by eHealthMe based on reports of 7,889 people who have side effects when taking Humatrope from the FDA, and is updated regularly.

What is Humatrope?

Humatrope has active ingredients of somatropin recombinant. It is often used in stature short abnormal. eHealthMe is studying from 7,932 Humatrope users. Check the latest studies of Humatrope.

What is Hyperkalemia?

Hyperkalemia (damage to or disease of the kidney) is found to be associated with 1,956 drugs and 2,936 conditions by eHealthMe. Check the latest studies of Hyperkalemia.

On Jul, 12, 2026

7,889 people reported to have side effects when taking Humatrope.
Among them, 11 people (0.14%) have Hyperkalemia.

Among these 11 people:

How long have people been on Humatrope when they have Hyperkalemia? *

What is the gender of people who have Hyperkalemia when taking Humatrope? *

female: 63.64 %
male: 36.36 %

What is the age of people who have Hyperkalemia when taking Humatrope? *

What are other drugs people take besides Humatrope? *

What are other side effects people have besides Hyperkalemia? *

Dehydration (dryness resulting from the removal of water): 7 people, 63.64%
Nausea (feeling of having an urge to vomit): 4 people, 36.36%
Tricuspid Valve Incompetence (inefficient heart valve): 2 people, 18.18%
Mitral Valve Incompetence (inefficient heart valve): 2 people, 18.18%
Diarrhea: 2 people, 18.18%
Dyspnea (difficult or laboured breathing): 2 people, 18.18%
Hyponatremia (abnormally low level of sodium in the blood; associated with dehydration): 2 people, 18.18%
Meningioma (a diverse set of tumours arising from the meninges): 2 people, 18.18%
Gastrointestinal Disorder (functional problems of gastrointestinal tract): 2 people, 18.18%
Nausea And Vomiting: 2 people, 18.18%

What are the existing conditions these people have? *

Renal Disorder (kidney disease): 1 person, 9.09%
Post Procedural Complication: 1 person, 9.09%
Hypopituitarism (diminished hormone secretion by the pituitary gland, causing dwarfism in children and premature aging in adults): 1 person, 9.09%
Fluid Retention (an abnormal accumulation of fluid in the blood): 1 person, 9.09%
Cardiac Failure: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Humatrope and have Hyperkalemia?

- Check whether Hyperkalemia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Humatrope:

Humatrope (7,932 reports)

Hyperkalemia treatments and more:

Hyperkalemia (78,084 reports)

Browse all side effects of Humatrope:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hyperkalemia:

Hyperkalemia (1,956 drugs)

Browse all the conditions that are associated with Hyperkalemia:

Hyperkalemia (2,936 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on somatropin recombinant (the active ingredients of Humatrope) and Humatrope (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.